A consortium led by Eone Diagnomics Genome Center, a South Korea-based healthcare company engaged in genetic analysis, will provide a DNA-based health prediction service in a metaverse platform to help business partners create new business models based on genomic big data. A beta service involving consortium partners is underway, with an official service to be launched as early as this year.
The project aims to move the real world step by step into the virtual world like a mirror. It is a fourth-generation social network service that combines reality and virtual reality to allow hundreds of millions of users to mingle together using avatars and enable various commercial transactions as well as social and economic activities such as performances, games, fashion, and smart healthcare.
It is a customized service that matches genetic data collected by Eone Diagnomics Genome Center (EDGC) with individual genetic data uploaded by users. The primary profit model is to create value by using cyber models and establishing a meta-commerce ecosystem through games. Companies can quickly and safely market new technologies through virtual spaces.
"It is the first project to try and develop a metaverse platform that can make avatars by analyzing DNA through saliva collection," EDGC's public relations official Kim Seon-gyun told Aju Business Daily. "Using EDGC's genetic big data, consortium partners can develop new products and services and implement new business models on the metaverse platform."